DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Wet Age Related Macular Degeneration (AMD) Market: Industry Analysis & Outlook (2017-2021)" report to their offering.
"Global Wet AMD Market: Industry Analysis & Outlook (2017-2021)" analyses the development of this market, with focus on the U.S. and outside the U.S. markets. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report.
The four major players: Regeneron Pharmaceuticals, Inc. Novartis International AG, Roche Holding AG & Bayer Group are profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global wet AMD market along with the study of the regional markets.
The global wet AMD market is set to experience favourable growth driven by factors such as increasing elderly population & rising health care expenditure. Further, the scope of growth for this market will be broadened by increasing obese population and global economic development. However, growth of this budding market will be hindered by lack of trained ophthalmologists, high cost of wet AMD drugs and associated high risk.
- Rising Aging Population
- Rising Healthcare Expenditure
- Increasing Obese Population
- Economic Development
- Several Drugs Under Pipeline for AMD
- Novel Techniques for Wet AMD Drugs
- Increasing Research Grants and Awareness for Wet AMD
- Lack of Trained Ophthalmologists
- High Cost of Wet AMD Drugs
- Associated High Risk
Key Topics Covered:
1. Market Overview
2. Global Market Analysis
3. Regional Market Analysis
4. Market Dynamics
6. Company Profiles
- Bayer Group
- Novartis International AG
- Regeneron Pharmaceuticals, Inc.
- Roche Holding AG
For more information about this report visit http://www.researchandmarkets.com/research/25szln/global_wet_age